Condition
Striae
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
40%
2 of 5 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (4)
P 1 (1)
P 4 (1)
Trial Status
Completed5
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07154030Phase 1Not Yet RecruitingPrimary
Efficacy Of Combined Microneedling Plus Tretinoin In Treatment Of Stria Rubra
NCT01745211Not ApplicableCompletedPrimary
755nm Alex Laser for Treatment of Stretch Marks
NCT01027793Phase 4Completed
Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks
NCT01810484Not ApplicableCompleted
Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment
NCT01796626Not ApplicableCompleted
Clinical Evaluation of M22 ResurFX 1565nm Module
NCT01788748Not ApplicableCompletedPrimary
Evaluation of Fractional Bipolar Radiofrequency for the Treatment of Striae
Showing all 6 trials